LGM Pharma recalls CIDOFOVIR DIHYDRATE for FDA Import Alert
LGM Pharma recalls CIDOFOVIR DIHYDRATE (10g, Rx only) due to FDA Import Alert on API manufacturer. This product is for manufacturing use only, not for patient consumption.
Recall notice
CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Contact the company
What happened, in plain English
LGM Pharma is recalling CIDOFOVIR DIHYDRATE (10g, prescription-only) for manufacturing use because the API manufacturer is on an FDA Import Alert. This recall does not affect patients using the drug. Read more at govinfonow.com/recall/39311-lgm-pharma-recalls-cidofovir-dihydrate-for-fda-import-alert.
Source Summary by GovInfoNow · govinfonow.com/recall/39311-lgm-pharma-recalls-cidofovir-dihydrate-for-fda-import-alert · Updated October 5, 2026 · FDA enforcement record: FDA #D-0486-2019
Cite this page
“LGM Pharma recalls CIDOFOVIR DIHYDRATE for FDA Import Alert.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39311-lgm-pharma-recalls-cidofovir-dihydrate-for-fda-import-alert. Based on FDA recall #D-0486-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0486-2019%22&limit=1).
Why it’s dangerous
The API manufacturer is listed on an FDA Import Alert, which means the product may not meet quality standards. However, this recall is for manufacturing use only, not for patient consumption.
Who’s affected
Manufacturers and facilities using this product for pharmaceutical production are affected. Patients using the drug for medical treatment are not at risk as this product is for manufacturing use only.
How to tell if you have this one
Check for the product name CIDOFOVIR DIHYDRATE (10g, Rx only) with batch number JD-BP-37-20150801. This product is manufactured by ALP PHARM BEIJING CO., LTD in Beijing, China.
- Brand
LGM Pharma- Category
Drug
What to do — step by step
Check Product Details
Verify the batch number JD-BP-37-20150801 on the product label.
Where it went and when
Where it was distributed
Distributed in Mississippi, and outside the U.S.
FDA distribution: “Distributed to MS and Spain” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Mississippi.
Recall timeline
FDA terminated this recall 4.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Why is this product being recalled?
The API manufacturer is on an FDA Import Alert, which indicates potential quality concerns.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0486-2019 (December 18, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0486-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.